Recombinant multi-species BHLHE40 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BHLHE40 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a basic helix-loop-helix protein expressed in various tissues. The encoded protein can interact with ARNTL or compete for E-box binding sites in the promoter of PER1 and repress CLOCK/ARNTL's transactivation of PER1. This gene is believed to be involved in the control of circadian rhythm and cell differentiation. [provided by RefSeq, Feb 2014]
The Alternative Names of target: BHLHB2,BHLHE40,Bhlhb2,Bhlhe40,C130042M06Rik,CR8,Class B basic helix-loop-helix protein 2 (bHLHb2),Class E basic helix-loop-helix protein 40,Clast5,DEC1,Dec1,Differentially expressed in chondrocytes protein 1 (DEC1),Enhancer-of-split and hairy-related protein 2 (SHARP-2),HLHB2,SHARP-2,SHARP2,STRA13,Sharp2,Stimulated by retinoic acid gene 13 protein,Stra13,Stra14,bHLHe40

Target products collectionGo to BHLHE40 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13190-Ag-1/ GM-Tg-hg-IP13190-Ag-2 Human BHLHE40 protein Human
GM-Tg-rg-IP13190-Ag-1/ GM-Tg-rg-IP13190-Ag-2 Rat BHLHE40 protein Rat
GM-Tg-mg-IP13190-Ag-1/ GM-Tg-mg-IP13190-Ag-2 Mouse BHLHE40 protein Mouse
GM-Tg-cynog-IP13190-Ag-1/ GM-Tg-cynog-IP13190-Ag-2 Cynomolgus/Rhesus macaque BHLHE40 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13190-Ag-1/ GM-Tg-felg-IP13190-Ag-2 Feline BHLHE40 protein Feline
GM-Tg-cang-IP13190-Ag-1/ GM-Tg-cang-IP13190-Ag-2 Canine BHLHE40 protein Canine
GM-Tg-bovg-IP13190-Ag-1/ GM-Tg-bovg-IP13190-Ag-2 Bovine BHLHE40 protein Bovine
GM-Tg-equg-IP13190-Ag-1/ GM-Tg-equg-IP13190-Ag-2 Equine BHLHE40 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13190-Ag-1/ GM-Tg-hg-IP13190-Ag-2; GM-Tg-rg-IP13190-Ag-1/ GM-Tg-rg-IP13190-Ag-2;
GM-Tg-mg-IP13190-Ag-1/ GM-Tg-mg-IP13190-Ag-2; GM-Tg-cynog-IP13190-Ag-1/ GM-Tg-cynog-IP13190-Ag-2;
GM-Tg-felg-IP13190-Ag-1/ GM-Tg-felg-IP13190-Ag-2; GM-Tg-cang-IP13190-Ag-1/ GM-Tg-cang-IP13190-Ag-2;
GM-Tg-bovg-IP13190-Ag-1/ GM-Tg-bovg-IP13190-Ag-2; GM-Tg-equg-IP13190-Ag-1/ GM-Tg-equg-IP13190-Ag-2
Products Name BHLHE40 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name BHLHE40
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BHLHE40 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.